当前位置： SCI文献检索 > Molecular Cancer期刊下所有文献 > Role of the NLRP3 inflammasome in cancer.

Role of the NLRP3 inflammasome in cancer.

Abstract：

:Inflammasomes are large intracellular multi-protein signalling complexes that are formed in the cytosolic compartment as an inflammatory immune response to endogenous danger signals. The formation of the inflammasome enables activation of an inflammatory protease caspase-1, pyroptosis initiation with the subsequent cleaving of the pro-inflammatory cytokines interleukin (IL)-1β and proIL-18 to produce active forms. The inflammasome complex consists of a Nod-like receptor (NLR), the adapter apoptosis-associated speck-like (ASC) protein, and Caspase-1. Dysregulation of NLRP3 inflammasome activation is involved tumor pathogenesis, although its role in cancer development and progression remains controversial due to the inconsistent findings described. In this review, we summarize the current knowledge on the contribution of the NLRP3 inflammasome on potential cancer promotion and therapy.

journal_name

Mol Cancer

journal_title

Molecular cancer

authors

Moossavi M,Parsamanesh N,Bahrami A,Atkin SL,Sahebkar A

doi

10.1186/s12943-018-0900-3

subject

Has Abstract

pub_date

2018-11-17 00:00:00

pages

158

issue

1

issn

1476-4598

pii

10.1186/s12943-018-0900-3

journal_volume

17

pub_type

杂志文章,评审

相关文献

Molecular Cancer文献大全
  • LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.

    abstract：BACKGROUND:Relapse due to chemoresistant residual disease is a major cause of death in acute myelogenous leukemia (AML). The present study was undertaken to elucidate the molecular mechanisms of chemoresistance by comparing differential gene expression in blasts from patients with resistant relapsing AML and chemosensi...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-6-31

    authors： Huang TS,Myklebust LM,Kjarland E,Gjertsen BT,Pendino F,Bruserud Ø,Døskeland SO,Lillehaug JR

    更新日期：2007-04-23 00:00:00

  • Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2.

    abstract：BACKGROUND:Taurine upregulated gene1 (TUG1) as a 7.1-kb lncRNA, has been shown to play an oncogenic role in various cancers. However, the biological functions of lncRNA TUG1 in small cell lung cancer (SCLC) remain unknown. The aim of this study is to explore the roles of TUG1 in cell growth and chemoresistance of SCLC ...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-016-0575-6

    authors： Niu Y,Ma F,Huang W,Fang S,Li M,Wei T,Guo L

    更新日期：2017-01-09 00:00:00

  • Oncogenic KRAS promotes malignant brain tumors in zebrafish.

    abstract：BACKGROUND:Zebrafish have been used as a vertebrate model to study human cancers such as melanoma, rhabdomyosarcoma, liver cancer, and leukemia as well as for high-throughput screening of small molecules of therapeutic value. However, they are just emerging as a model for human brain tumors, which are among the most de...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-015-0288-2

    authors： Ju B,Chen W,Orr BA,Spitsbergen JM,Jia S,Eden CJ,Henson HE,Taylor MR

    更新日期：2015-02-03 00:00:00

  • Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma.

    abstract：BACKGROUND:Though esophageal cancer is three to four times more common among males than females worldwide, this type of cancer still ranks in the top incidence among women, even more than the female specific cancer types. The occurrence is currently attributed to extrinsic factors, including tobacco use and alcohol con...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-019-0949-7

    authors： Li W,Zhang L,Guo B,Deng J,Wu S,Li F,Wang Y,Lu J,Zhou Y

    更新日期：2019-02-08 00:00:00

  • Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression.

    abstract：:Cancer precursor/progenitor cells may initiate and sustain the growth of tumors, but evidence for their existence in human disease is indirect, relying on their in vitro properties and animal models. More directly, specific elimination of these rare cells from cancer patients should produce a delayed but progressive d...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-8-106

    authors： Foster AE,Okur FV,Biagi E,Lu A,Dotti G,Yvon E,Savoldo B,Carrum G,Andreeff M,Goodell MA,Heslop HE,Brenner MK

    更新日期：2009-11-18 00:00:00

  • Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.

    abstract：BACKGROUND:Esophageal squamous cell carcinoma (ESCC) is highly malignant with highly invasive and metastatic capabilities and poor prognosis. It is believed that the ESCC cancer stem-like cells (ECSLCs) are critical for tumorigenicity, invasion and metastasis of ESCC. However, the properties of ECSLCs vary with differe...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-017-0650-7

    authors： Liu Q,Cui X,Yu X,Bian BS,Qian F,Hu XG,Ji CD,Yang L,Ren Y,Cui W,Zhang X,Zhang P,Wang JM,Cui YH,Bian XW

    更新日期：2017-04-21 00:00:00

  • Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.

    abstract：BACKGROUND:Acute lymphoblastic leukemia (ALL) is the most common hematological malignancy affecting children. Despite significant progress and success in the treatment of ALL, a significant number of children continue to relapse and for them, outcome remains poor. Therefore, the search for novel therapeutic approaches ...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-6-46

    authors： Sengupta TK,Leclerc GM,Hsieh-Kinser TT,Leclerc GJ,Singh I,Barredo JC

    更新日期：2007-07-10 00:00:00

  • Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines.

    abstract：BACKGROUND:Gefitinib is a tyrosine kinase inhibitor (TKI) of the epidermal growth factor receptor (EGFR) especially effective in tumors with activating EGFR gene mutations while EGFR wild-type non small cell lung cancer (NSCLC) patients at present do not benefit from this treatment.The primary site of gefitinib metabol...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-10-143

    authors： Alfieri RR,Galetti M,Tramonti S,Andreoli R,Mozzoni P,Cavazzoni A,Bonelli M,Fumarola C,La Monica S,Galvani E,De Palma G,Mutti A,Mor M,Tiseo M,Mari E,Ardizzoni A,Petronini PG

    更新日期：2011-11-23 00:00:00

  • Role of hypoxia-induced exosomes in tumor biology.

    abstract：PURPOSE:Hypoxia is a major regulator of angiogenesis and always influences the release of exosomes in various types of tumors. The present review aimed to assess the role of hypoxia-induced exosomes in the tumor biology. METHODS:The relevant publications were retrieved from PubMed using keywords such as hypoxia, exoso...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-018-0869-y

    authors： Shao C,Yang F,Miao S,Liu W,Wang C,Shu Y,Shen H

    更新日期：2018-08-11 00:00:00

  • Functional roles of circular RNAs during epithelial-to-mesenchymal transition.

    abstract：:Cancer has become a major health issue worldwide, contributing to a high mortality rate. Tumor metastasis is attributed to the death of most patients. Epithelial-to-mesenchymal transition (EMT) plays a vital role in inducing metastasis. During EMT, epithelial cells lose their characteristics, such as cell-to-cell adhe...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-019-1071-6

    authors： Shang BQ,Li ML,Quan HY,Hou PF,Li ZW,Chu SF,Zheng JN,Bai J

    更新日期：2019-09-16 00:00:00

  • The MUC gene family: their role in diagnosis and early detection of pancreatic cancer.

    abstract：:The early diagnosis of pancreatic cancer, as well as distinguishing between chronic pancreatitis and malignant pancreatic disease, remains still a clinical problem. Presently, there is no specific tumor marker for diagnosing pancreatic cancer. Mucin-associated marker like CA 19-9 are the most widely available pancreat...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：

    authors： Ringel J,Löhr M

    更新日期：2003-01-07 00:00:00

  • Circular RNA: metabolism, functions and interactions with proteins.

    abstract：:Circular RNAs (CircRNAs) are single-stranded, covalently closed RNA molecules that are ubiquitous across species ranging from viruses to mammals. Important advances have been made in the biogenesis, regulation, localization, degradation and modification of circRNAs. CircRNAs exert biological functions by acting as tra...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-020-01286-3

    authors： Zhou WY,Cai ZR,Liu J,Wang DS,Ju HQ,Xu RH

    更新日期：2020-12-14 00:00:00

  • Overexpression of Eag1 potassium channels in clinical tumours.

    abstract：BACKGROUND:Certain types of potassium channels (known as Eag1, KCNH1, Kv10.1) are associated with the production of tumours in patients and in animals. We have now studied the expression pattern of the Eag1 channel in a large range of normal and tumour tissues from different collections utilising molecular biological a...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-5-41

    authors： Hemmerlein B,Weseloh RM,Mello de Queiroz F,Knötgen H,Sánchez A,Rubio ME,Martin S,Schliephacke T,Jenke M,Heinz-Joachim-Radzun,Stühmer W,Pardo LA

    更新日期：2006-10-05 00:00:00

  • Correction to: Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells.

    abstract：:After the publication of this work [1], an error was found in Fig. 1b. As described in the Results section that circ0084003 has 13 exons, it should be formed by 5-17 (13exons) exons, authors have described "formed by 5-19 exons". The authors extend their apology for the mistake caused by their action. With that mistak...

    journal_title：Molecular cancer

    pub_type： 已发布勘误

    doi：10.1186/s12943-020-1131-y

    authors： Zhang PF,Pei X,Li KS,Jin LN,Wang F,Wu J,Zhang XM

    更新日期：2020-02-01 00:00:00

  • The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation.

    abstract：BACKGROUND:Recent advances have revealed a significant contribution of chemokines and their receptors in tumor growth, survival after chemotherapy, and organ-specific metastasis. The CXC chemokine receptor-7 (CXCR7) is the latest chemokine receptor implicated in cancer. Although over expressed in breast cancer cell lin...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-13-198

    authors： Salazar N,Muñoz D,Kallifatidis G,Singh RK,Jordà M,Lokeshwar BL

    更新日期：2014-08-28 00:00:00

  • MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.

    abstract：BACKGROUND:Fusion of the MOZ and TIF2 genes by an inv (8) (p11q13) translocation has been identified in patients with acute mixed-lineage leukemia. Characterization of the molecular structure of the MOZ-TIF2 fusion protein suggested that the fusion protein would effect on nuclear receptor signaling. RESULTS:A series o...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-6-51

    authors： Yin H,Glass J,Blanchard KL

    更新日期：2007-08-13 00:00:00

  • Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.

    abstract：BACKGROUND:Alterations of chromosome 8 and hypomethylation of LINE-1 retrotransposons are common alterations in advanced prostate carcinoma. In a former study including many metastatic cases, they strongly correlated with each other. To elucidate a possible interaction between the two alterations, we investigated their...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-6-14

    authors： Schulz WA,Alexa A,Jung V,Hader C,Hoffmann MJ,Yamanaka M,Fritzsche S,Wlazlinski A,Müller M,Lengauer T,Engers R,Florl AR,Wullich B,Rahnenführer J

    更新日期：2007-02-05 00:00:00

  • Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes.

    abstract：BACKGROUND:The human cell cycle transcription factor FOXM1 is known to play a key role in regulating timely mitotic progression and accurate chromosomal segregation during cell division. Deregulation of FOXM1 has been linked to a majority of human cancers. We previously showed that FOXM1 was upregulated in basal cell c...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-45

    authors： Teh MT,Gemenetzidis E,Chaplin T,Young BD,Philpott MP

    更新日期：2010-02-26 00:00:00

  • Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.

    abstract：BACKGROUND:Reactive oxygen species contribute to normal thyroid function. The NRF2 oxidative response pathway is frequently and constitutively activated in multiple tumor types, including papillary thyroid carcinoma (PTC). Genetic mechanisms underlying NRF2 pathway activation in PTC are not fully understood. Thus, we a...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-12-124

    authors： Martinez VD,Vucic EA,Pikor LA,Thu KL,Hubaux R,Lam WL

    更新日期：2013-10-20 00:00:00

  • IRF5 promotes the proliferation of human thyroid cancer cells.

    abstract：BACKGROUND:Interferon Regulatory Factor 5 is a transcription factor that regulates the expression of genes involved in the response to viral infection and in the stimulation of the immune system. Moreover, multiple studies have demonstrated that it negatively regulates cell growth and oncogenesis, favoring cell differe...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-11-21

    authors： Massimino M,Vigneri P,Fallica M,Fidilio A,Aloisi A,Frasca F,Manzella L

    更新日期：2012-04-16 00:00:00

  • NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3.

    abstract：BACKGROUND:Human or animals lacking either JAK3 or the common gamma chain (gammac) expression display severe combined immunodeficiency disease, indicating the crucial role of JAK3 in T-cell development and the homeostasis of the immune system. JAK3 has also been suggested to contribute to the pathogenesis of tumorigene...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-36

    authors： Kim BH,Jee JG,Yin CH,Sandoval C,Jayabose S,Kitamura D,Bach EA,Baeg GH

    更新日期：2010-02-11 00:00:00

  • Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib.

    abstract：BACKGROUND:Sorafenib, a kinase inhibitor active against various solid tumours, induces oxidative stress and ferroptosis, a new form of oxidative necrosis, in some cancer cells. Clinically-applicable biomarkers that reflect the impact of sorafenib on the redox metabolism of cancer cells are lacking. METHODS:We used gen...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-016-0526-2

    authors： Houessinon A,François C,Sauzay C,Louandre C,Mongelard G,Godin C,Bodeau S,Takahashi S,Saidak Z,Gutierrez L,Régimbeau JM,Barget N,Barbare JC,Ganne N,Chauffert B,Coriat R,Galmiche A

    更新日期：2016-05-16 00:00:00

  • Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells.

    abstract：BACKGROUND:Peroxisome proliferator-activated receptor gamma (PPARgamma) is a member of the nuclear hormone receptor superfamily and is highly expressed in many human tumors including breast cancer. PPARgamma has been identified as a potential target for breast cancer therapy based on the fact that its activation by syn...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-7-90

    authors： Zaytseva YY,Wang X,Southard RC,Wallis NK,Kilgore MW

    更新日期：2008-12-05 00:00:00

  • Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.

    abstract：BACKGROUND:TGF-β promotes tumor invasion and metastasis through inducing epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC). Circular RNAs (circRNAs) are recognized as functional non-coding RNAs involved in human cancers. However, whether and how circRNAs contribute to TGF-β-induced EMT and m...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-018-0889-7

    authors： Wang L,Tong X,Zhou Z,Wang S,Lei Z,Zhang T,Liu Z,Zeng Y,Li C,Zhao J,Su Z,Zhang C,Liu X,Xu G,Zhang HT

    更新日期：2018-09-27 00:00:00

  • Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1.

    abstract：BACKGROUND:CADM1 encodes an immunoglobulin superfamily (IGSF) cell adhesion molecule. Inactivation of CADM1, either by promoter hypermethylation or loss of heterozygosity, has been reported in a wide variety of tumor types, thus it has been postulated as a tumor suppressor gene. FINDINGS:We show for the first time tha...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-11-29

    authors： van der Weyden L,Arends MJ,Rust AG,Poulogiannis G,McIntyre RE,Adams DJ

    更新日期：2012-05-03 00:00:00

  • At the crossroads of SUMO and NF-kappaB.

    abstract：BACKGROUND:Recognition of pathogens by immune receptors leads to activation of macrophages, dendritic cells, and lymphocytes. Signals are communicated to enhance expression of target molecules such as cytokines and adhesion molecules, depending on activation of various inducible transcription factors, among which the f...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-2-39

    authors： Kracklauer MP,Schmidt C

    更新日期：2003-11-05 00:00:00

  • The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines.

    abstract：BACKGROUND:The cyclin D1 proto-oncogene is an important regulator of G1 to S-phase transition and an important cofactor for several transcription factors in numerous cell types. Studies on neonatal cardiomyocytes and postmitotic neurons indicate that the activity of cyclin D1 may be regulated through its cytoplasmic se...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-5-7

    authors： Alao JP,Gamble SC,Stavropoulou AV,Pomeranz KM,Lam EW,Coombes RC,Vigushin DM

    更新日期：2006-02-17 00:00:00

  • Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion.

    abstract：BACKGROUND:ADAMTS-1 (a disintegrin and metalloprotease with thrombospondin motifs) is a member of the ADAMTS family of metalloproteases. Here, we investigated mRNA and protein levels of ADAMTS-1 in normal and neoplastic tissues using qPCR, immunohistochemistry and immunoblot analyses, and we addressed the role of ADAMT...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-12-2

    authors： Freitas VM,do Amaral JB,Silva TA,Santos ES,Mangone FR,Pinheiro Jde J,Jaeger RG,Nagai MA,Machado-Santelli GM

    更新日期：2013-01-05 00:00:00

  • CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer.

    abstract：BACKGROUND:Minimal residual disease is the main issue of advanced ovarian cancer treatment. According to the literature and previous results, we hypothesized that Mesenchymal Stromal Cells (MSC) could support this minimal residual disease by protecting ovarian cancer cells (OCC) from chemotherapy. In vitro study confir...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-018-0787-z

    authors： Pasquier J,Gosset M,Geyl C,Hoarau-Véchot J,Chevrot A,Pocard M,Mirshahi M,Lis R,Rafii A,Touboul C

    更新日期：2018-02-19 00:00:00

  • HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A.

    abstract：BACKGROUND:Targeted therapies have improved therapeutic options of treating renal cell carcinoma (RCC). However, drug response is temporary due to resistance development. METHODS:Functional and molecular changes in RCC Caki-1 cells, after acquired resistance to the mammalian target of rapamycin (mTOR)-inhibitor everol...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-13-152

    authors： Juengel E,Nowaz S,Makarevi J,Natsheh I,Werner I,Nelson K,Reiter M,Tsaur I,Mani J,Harder S,Bartsch G,Haferkamp A,Blaheta RA

    更新日期：2014-06-16 00:00:00